Venrock Healthcare Capital Partners

Venrock Healthcare Capital Partners accounts for 18 tracked companies with verified cap-table data, 18 of which disclose round sizes totalling $4.2B. The median disclosed raise is $175M, and the largest is Mirador Therapeutics at $650M, ahead of Spyre Therapeutics ($644M) and RayzeBio ($418M).

The names that recur most often on these co-invested cap tables are Venrock Healthcare Capital Partners (18 companies), Fairmount (7 companies), OrbiMed (5 companies), TCGX (4 companies), Cormorant Asset Management (4 companies), Vivo Capital (4 companies). By latest disclosed round, the market skews Series A (5), Series B (4), Series D (3), Series C (3).

• Companies tracked: 18
• Disclosed funding total: $4.2B across 18 companies
• Median disclosed raise: $175M
• Largest raise: Mirador Therapeutics — $650M
• Stage mix: Series A 5 · Series B 4 · Series D 3 · Series C 3
• Most recent dated round: 2026-06-01

Best funded Venrock Healthcare Capital Partners companies

1. Mirador Therapeutics — $650M (latest: Series B)
2. Spyre Therapeutics — $644M (latest: Growth)
3. RayzeBio — $418M (latest: Series D)
4. Candid Therapeutics — $370M (latest: Series A)
5. CVRx — $340M
6. Lycia Therapeutics — $232M (latest: Series D)
7. ADARx Pharmaceuticals — $200M (latest: Series C)
8. Timberlyne Therapeutics — $180M (latest: Series A)
9. Korsana Biosciences — $175M (latest: Series A)
10. Celcuity — $175M (latest: Series B)
11. Apogee Therapeutics — $169M (latest: Series B)
12. Tricida — $153M (latest: Series D)
13. Jade Biosciences — $125M
14. Dianthus Therapeutics — $100M (latest: Series A)
15. Olema Oncology — $85M (latest: Series C)

Venrock Healthcare Capital Partners — related firms and companies (56)

• Mirador Therapeutics
• Spyre Therapeutics
• RayzeBio
• Candid Therapeutics
• CVRx
• Lycia Therapeutics
• ADARx Pharmaceuticals
• Timberlyne Therapeutics
• Investors like Alumni Ventures
• Investors like Goldman Sachs
• Venrock Healthcare Capital Partners portfolio companies 2026
• Investors like GIC
• Investors like Battery Ventures
• Humanigen
• Investors like boldstart ventures
• Investors like Thirdbase Capital
• Catabasis Pharmaceuticals
• Investors like Western Technology Investment
• Investors like Shasta Ventures
• Ablaze Pharmaceuticals
• Investors like Sapphire Ventures
• Investors like Digital Currency Group
• Olema Oncology
• Investors like CRV
• Investors like DCVC
• Dianthus Therapeutics
• Investors like Bienville Capital
• Investors like Slow Ventures
• Jade Biosciences
• Investors like Irving Investors
• Investors like Andreessen Horowitz
• Tricida
• Investors like Thrive Capital
• Investors like QED Investors
• Apogee Therapeutics
• Investors like Floodgate
• Investors like Point72 Ventures
• Celcuity
• Investors like Spark Capital
• Investors like Scale Venture Partners
• Korsana Biosciences
• Investors like Khosla Ventures
• Investors like Foundation Capital
• Investors like Eniac Ventures
• Investors like Sofinnova Investments
• Investors like BoxGroup
• Investors like Upfront Ventures
• Investors like GSR Ventures
• Investors like Ventioneers
• Investors like Lightspeed Venture Partners
• Investors like International Finance Corporation
• Investors like Acre Venture Partners
• Investors like Bond
• Founders backed by Venrock Healthcare Capital Partners
• Investors like Service Provider Capital
• Investors like Script Capital

Venrock Healthcare Capital Partners alternatives · All research reports